Cargando…
Spinal Biologics in Minimally Invasive Lumbar Surgery
As the use of minimally invasive spine (MIS) fusion approaches continues to grow, increased scrutiny is being placed on its outcomes and efficacies against traditional open fusion surgeries. While there are many factors that contribute to the success of achieving spinal arthrodesis, selecting the op...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907390/ https://www.ncbi.nlm.nih.gov/pubmed/29850240 http://dx.doi.org/10.1155/2018/5230350 |
_version_ | 1783315521747288064 |
---|---|
author | Chang, Kevin Y. Hsu, Wellington K. |
author_facet | Chang, Kevin Y. Hsu, Wellington K. |
author_sort | Chang, Kevin Y. |
collection | PubMed |
description | As the use of minimally invasive spine (MIS) fusion approaches continues to grow, increased scrutiny is being placed on its outcomes and efficacies against traditional open fusion surgeries. While there are many factors that contribute to the success of achieving spinal arthrodesis, selecting the optimal fusion biologic remains a top priority. With an ever-expanding market of bone graft substitutes, it is important to evaluate each of their use as it pertains to MIS techniques. This review will summarize the important characteristics and properties of various spinal biologics used in minimally invasive lumbar surgeries and compare their fusion rates via a systematic review of published literature. |
format | Online Article Text |
id | pubmed-5907390 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-59073902018-05-30 Spinal Biologics in Minimally Invasive Lumbar Surgery Chang, Kevin Y. Hsu, Wellington K. Minim Invasive Surg Review Article As the use of minimally invasive spine (MIS) fusion approaches continues to grow, increased scrutiny is being placed on its outcomes and efficacies against traditional open fusion surgeries. While there are many factors that contribute to the success of achieving spinal arthrodesis, selecting the optimal fusion biologic remains a top priority. With an ever-expanding market of bone graft substitutes, it is important to evaluate each of their use as it pertains to MIS techniques. This review will summarize the important characteristics and properties of various spinal biologics used in minimally invasive lumbar surgeries and compare their fusion rates via a systematic review of published literature. Hindawi 2018-04-05 /pmc/articles/PMC5907390/ /pubmed/29850240 http://dx.doi.org/10.1155/2018/5230350 Text en Copyright © 2018 Kevin Y. Chang and Wellington K. Hsu. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Chang, Kevin Y. Hsu, Wellington K. Spinal Biologics in Minimally Invasive Lumbar Surgery |
title | Spinal Biologics in Minimally Invasive Lumbar Surgery |
title_full | Spinal Biologics in Minimally Invasive Lumbar Surgery |
title_fullStr | Spinal Biologics in Minimally Invasive Lumbar Surgery |
title_full_unstemmed | Spinal Biologics in Minimally Invasive Lumbar Surgery |
title_short | Spinal Biologics in Minimally Invasive Lumbar Surgery |
title_sort | spinal biologics in minimally invasive lumbar surgery |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907390/ https://www.ncbi.nlm.nih.gov/pubmed/29850240 http://dx.doi.org/10.1155/2018/5230350 |
work_keys_str_mv | AT changkeviny spinalbiologicsinminimallyinvasivelumbarsurgery AT hsuwellingtonk spinalbiologicsinminimallyinvasivelumbarsurgery |